Photocil (Topical) for the Treatment of Atopic Dermatitis
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B
(NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from
non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light
in the NB-UVB range with peak transmission of 308nm. The aim of the study is to assess the
safety and efficacy of Photocil in the treatment of atopic dermatitis.